Article(id=1330233614907846708, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233532238115104, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.01.018, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1693497600000, receivedDateStr=2023-09-01, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795082008339, onlineDateStr=2026-11-19, pubDate=1704816000000, pubDateStr=2024-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795082008339, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795082008339, creator=13701087609, updateTime=1795082008339, updator=13701087609, issue=Issue{id=1330233532238115104, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='1', pageStart='1', pageEnd='164', issueExtLink='null', onlineDate='null', pubDate='1704816000000', pubDateStr='2024-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795081988628, creator='13701087609', updateTime=1795082672017, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330236399149756518, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233532238115104, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330236399149756519, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233532238115104, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=132, endPage=136, ext={EN=ArticleExt(id=1330233615075618869, articleId=1330233614907846708, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Brief Analysis of FDA Approved Orphan Drugs, columnId=1322624444787438528, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Pharmaceutical Management & Information, runingTitle=null, highlight=null, articleAbstract=null, authors=Yinghui YU1, Yang TAN1, Guiliang CHEN2, *, authorsList=Yinghui YU, Yang TAN, Guiliang CHEN, authorCompany=null, correspAuthors=Guiliang CHEN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330233615667015734, articleId=1330233614907846708, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=FDA获批孤儿药情况简析, columnId=1322624444934239170, journalTitle=中国医药工业杂志, columnName=药学管理与信息, runingTitle=null, highlight=null, articleAbstract=

文章分析了目前美国的孤儿药认证和获批情况。从1983年1月4日到2023年6月30日,FDA共授予了4 868个通用名药物6 749个孤儿药认证,其中700个药物已获得FDA批准上市。这些获批的孤儿药来自328家企业,其中大型跨国药企在孤儿药开发中发挥着重要作用。在获批孤儿药的适应证中,仅269种被Orphanet数据库收录,覆盖率不足5%。获批孤儿药的种类较多,以化学药为主,其中寡核苷酸等多种新型孤儿药也获批上市;另外,在生物药中,细胞和基因治疗是近年来出现的新类别。总体而言,美国孤儿药政策促进了药物的研发,我国在制定相关政策时可借鉴美国的研发管理经验,要从罕见病患者角度出发,确保药物研发满足真正的临床需求。

, authors=俞颖慧1, 谭洋1, 陈桂良2, *, authorsList=俞颖慧, 谭洋, 陈桂良, authorCompany=null, correspAuthors=陈桂良, authorNote=

俞颖慧(1984—),女,博士研究生,专业方向:社会管理药学。

, correspAuthorsNote=
陈桂良(1964—),男,研究员,博士生导师,从事药品监管科学。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=OqAxKaMf/9BVGGjjrmywnQ==, magXml=b5ol/j7SoUEG8piKUBb7ew==, pdfUrl=null, pdf=kXPg9/z64jy/yFLEL4iSkw==, pdfFileSize=2008359, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=QvnpsSsjPXyfL8CS+ARTuw==, mapNumber=null, fund=null)}, authors=[Author(id=1330233616031920190, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233617646727232, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, authorId=1330233616031920190, language=EN, stringName=Yinghui YU, firstName=Yinghui, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233617726419009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, authorId=1330233616031920190, language=CN, stringName=俞颖慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院中国医药工业信息中心,上海 200040, bio={"content":"

俞颖慧(1984—),女,博士研究生,专业方向:社会管理药学。

"}, bioImg=null, bioContent=

俞颖慧(1984—),女,博士研究生,专业方向:社会管理药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233615838982199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, xref=1., ext=[AuthorCompanyExt(id=1330233615847370808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615838982199, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200040), AuthorCompanyExt(id=1330233615855759417, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615838982199, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院中国医药工业信息中心,上海 200040)])]), Author(id=1330233617806110787, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233617877413957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, authorId=1330233617806110787, language=EN, stringName=Yang TAN, firstName=Yang, middleName=null, lastName=TAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233617952911430, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, authorId=1330233617806110787, language=CN, stringName=谭洋, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院中国医药工业信息中心,上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233615838982199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, xref=1., ext=[AuthorCompanyExt(id=1330233615847370808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615838982199, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200040), AuthorCompanyExt(id=1330233615855759417, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615838982199, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院中国医药工业信息中心,上海 200040)])]), Author(id=1330233618032603208, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=chenguiliang@smda.sh.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233618091323466, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, authorId=1330233618032603208, language=EN, stringName=Guiliang CHEN, firstName=Guiliang, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233618150043723, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, authorId=1330233618032603208, language=CN, stringName=陈桂良, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海药品审评核查中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233615948034106, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, xref=2., ext=[AuthorCompanyExt(id=1330233615956422715, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615948034106, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1330233615960617020, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615948034106, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海药品审评核查中心,上海 201203)])])], keywords=[Keyword(id=1330233618254901324, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, language=CN, orderNo=1, keyword=FDA), Keyword(id=1330233618347176013, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, language=CN, orderNo=2, keyword=孤儿药), Keyword(id=1330233618401701966, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, language=CN, orderNo=3, keyword=研发)], refs=[Reference(id=1330233618489782351, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=TAMBUYZER E, VANDENDRIESSCHE B, AUSTIN C P,et al.Therapies for rare diseases: therapeutic modalities, progress and challenges ahead [J].Nat Rev Drug Discov, 2020, 19(2): 93-111., articleTitle=null, refAbstract=null), Reference(id=1330233618548502608, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=RHEE T G.Policymaking for orphan drugs and its challenges [J].AMA J Ethics, 2020, 17(8): 776-779., articleTitle=null, refAbstract=null), Reference(id=1330233618619805777, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=黄方如,邵文斌.中国罕见病药物可及性报告2019 [EB/OL].(2019-02-28)[2023-07-29].https://www.iqvia.com/zh-cn/locations/china/library/brochures/viewpoint-issue-42., articleTitle=null, refAbstract=null), Reference(id=1330233618678526034, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG Y, KANG Q, HU J, et al.Accessibility of drugs for rare diseases in China: policies and current situation [J].Intractable Rare Dis Res, 2019, 8(2): 80-88., articleTitle=null, refAbstract=null), Reference(id=1330233618737246291, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=王雪,刘丽华,张绮,等.浅析美国罕见病治疗药物激励政策发展及对我国的启示[J].中国临床药理学杂志,2020,36(12):1768-1772., articleTitle=null, refAbstract=null), Reference(id=1330233618795966548, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Food & Drug Administration.FDA’s office of orphan products development(OOPD)-an overview and update[EB/OL].(2022-03-01)[2023-08-23].https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/fdas-office-orphan-products-development-oopd-overview-and-update., articleTitle=null, refAbstract=null), Reference(id=1330233618863075413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=杜涛,龚兆龙,高翼.美国孤儿药开发的政策、策略与实践[J].药学进展,2015,39(8):566-570., articleTitle=null, refAbstract=null), Reference(id=1330233618938572886, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Food & Drug Administration.Rare disease day 2021: FDA shows sustained support of rare disease product development during the public health emergency [EB/OL].(2021-03-01)[2023-08-23].https://www.fda.gov/news-events/fda-voices/rare-disease-day-2021-fda-shows-sustained-support-rare-disease-product-development-during-public., articleTitle=null, refAbstract=null), Reference(id=1330233619009876055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Food & Drug Administration.New drug approvals for 2022 [EB/OL].(2023-09-19)[2023-07-29].https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2022., articleTitle=null, refAbstract=null), Reference(id=1330233619068596312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=CHRISTEL M.2023 Pharm exec top 50 companies [EB/OL].(2023-06-11)[2023-07-29].https://www.pharmexec.com/view/2023-pharm-exec-top-50-companies., articleTitle=null, refAbstract=null), Reference(id=1330233619131510873, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=SENIOR M, HADJIVASILIOU A.Orphan drug report 2022[EB/OL].(2022-04-27)[2023-07-29].https://www.evaluate.com/thought-leadership/pharma/orphan-drug-2022-report., articleTitle=null, refAbstract=null), Reference(id=1330233619198619738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=田苗,田红,解学星,等.罕见病用药现状分析[J].现代药物与临床,2014,29(7):701-707., articleTitle=null, refAbstract=null), Reference(id=1330233619261534299, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=AHIP.The rise of orphan drugs [EB/OL].(2019-09-10)[2023-07-29].https://www.ahip.org/resources/the-rise-of-orphan-drugs., articleTitle=null, refAbstract=null), Reference(id=1330233619324448860, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=FU Z, LI S, HAN S, et al.Antibody drug conjugate: the “biological missile” for targeted cancer therapy [J].Signal Transduct Target Ther, 2022, 7(1): 93., articleTitle=null, refAbstract=null), Reference(id=1330233619404140637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=ROBERTS T C, LANGER R, WOOD M J A. Advances in oligonucleotide drug delivery [J]. Nat Rev Drug Discov, 2020, 19(10): 673-694., articleTitle=null, refAbstract=null), Reference(id=1330233619479638110, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=CAPPELL K M.KOCHENDERFER J N.Long-term outcomes following CAR T cell therapy: what we know so far [J].Nat Rev Clin Oncol, 2023, 20(6): 359-371., articleTitle=null, refAbstract=null), Reference(id=1330233619555135583, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=李玉欢,李伟.罕见病的基因治疗研究进展[J].罕少疾病杂志,2023,30(3):109-112., articleTitle=null, refAbstract=null), Reference(id=1330233619655798880, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=BENNETT J, MAGUIRE A M.Lessons learned from the development of the first FDA-approved gene therapy frug, voretigene neparvovec-rzyl [J].Cold Spring Harb Perspect Med, 2023, 13(5): a041307., articleTitle=null, refAbstract=null), Reference(id=1330233619739684961, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=WELLMAN-LABADIE O, ZHOU Y.The US orphan drug act: rare disease research stimulator or commercial opportunity? [J].Health policy, 2010, 95(2/3): 216-228., articleTitle=null, refAbstract=null), Reference(id=1330233619802599522, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Johnson & Johnson.Johnson & Johnson to acquire actelion for $30 billion with spin-out of new R&D company [EB/OL].[2023-08-22].https://www.jnj.com/media-center/press-releases/johnson-johnson-to-acquire-actelion., articleTitle=null, refAbstract=null), Reference(id=1330233619861319779, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=THE WALL STREET JOURNAL.At Takeda, M&A integration on a global fast track [EB/OL].(2021-12-11)[2023-08-22].https://deloitte.wsj.com/articles/at-takeda-m-a-integration-on-a-global-fast-track-01639165761., articleTitle=null, refAbstract=null), Reference(id=1330233619920040036, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=AstraZeneca.AstraZeneca to acquire Alexion, accelerating the company’s strategic and financial development [EB/OL].(2020-12-12)[2023-08-22].https://www.astrazeneca.com/media-centre/press-releases/2020/astrazeneca-to-acquire-alexion.html#!., articleTitle=null, refAbstract=null), Reference(id=1330233619987148901, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=AMGEN.Rule 2.7 announcement: amgen inc to acquire horizon therapeutics plc [EB/OL].(2022-12-12)[2023-08-22].https://www.amgen.com/newsroom/press-releases/2022/12/rule-2-7-announcement-amgen-inc-to-acquire-horizon-therapeutics-plc., articleTitle=null, refAbstract=null), Reference(id=1330233620066840678, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=人民网.《中国罕见病定义研究报告2021》发布[EB/OL].(2021-09-13)[2023-08-22].http://health.people.com.cn/n1/2021/0913/c14739-32225468.html., articleTitle=null, refAbstract=null), Reference(id=1330233620129755239, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=WU X, XU W, YU M.Clinical trials of orphan drugs in China over the decade 2012-2022: opportunities and challenges [J].Pharmacol Res, 2022, 182: 106349., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330233615838982199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, xref=1., ext=[AuthorCompanyExt(id=1330233615847370808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615838982199, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200040), AuthorCompanyExt(id=1330233615855759417, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615838982199, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院中国医药工业信息中心,上海 200040)]), AuthorCompany(id=1330233615948034106, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, xref=2., ext=[AuthorCompanyExt(id=1330233615956422715, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615948034106, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1330233615960617020, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615948034106, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海药品审评核查中心,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.01.018, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.01.018, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.01.018, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.01.018, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1704816000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
FDA获批孤儿药情况简析
俞颖慧 1 , 谭洋 1 , 陈桂良 2, *
中国医药工业杂志 | 药学管理与信息 2024,55(1): 132-136
收起
收藏切换
中国医药工业杂志 |药学管理与信息 2024 , 55 (1) : 132 -136
FDA获批孤儿药情况简析
全屏
[Author(id=1330233616031920190, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233617646727232, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, authorId=1330233616031920190, language=EN, stringName=Yinghui YU, firstName=Yinghui, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233617726419009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, authorId=1330233616031920190, language=CN, stringName=俞颖慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院中国医药工业信息中心,上海 200040, bio={"content":"

俞颖慧(1984—),女,博士研究生,专业方向:社会管理药学。

"}, bioImg=null, bioContent=

俞颖慧(1984—),女,博士研究生,专业方向:社会管理药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233615838982199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, xref=1., ext=[AuthorCompanyExt(id=1330233615847370808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615838982199, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200040), AuthorCompanyExt(id=1330233615855759417, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615838982199, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院中国医药工业信息中心,上海 200040)])]), Author(id=1330233617806110787, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233617877413957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, authorId=1330233617806110787, language=EN, stringName=Yang TAN, firstName=Yang, middleName=null, lastName=TAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233617952911430, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, authorId=1330233617806110787, language=CN, stringName=谭洋, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.中国医药工业研究总院中国医药工业信息中心,上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233615838982199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, xref=1., ext=[AuthorCompanyExt(id=1330233615847370808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615838982199, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200040), AuthorCompanyExt(id=1330233615855759417, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615838982199, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院中国医药工业信息中心,上海 200040)])]), Author(id=1330233618032603208, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=chenguiliang@smda.sh.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233618091323466, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, authorId=1330233618032603208, language=EN, stringName=Guiliang CHEN, firstName=Guiliang, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233618150043723, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, authorId=1330233618032603208, language=CN, stringName=陈桂良, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海药品审评核查中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233615948034106, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, xref=2., ext=[AuthorCompanyExt(id=1330233615956422715, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615948034106, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1330233615960617020, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233614907846708, companyId=1330233615948034106, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海药品审评核查中心,上海 201203)])])]
俞颖慧1, 谭洋1, 陈桂良2, *
作者信息
  • 1.中国医药工业研究总院中国医药工业信息中心,上海 200040
  • 2.上海药品审评核查中心,上海 201203
通讯作者:
陈桂良(1964—),男,研究员,博士生导师,从事药品监管科学。E-mail:
作者简介:

俞颖慧(1984—),女,博士研究生,专业方向:社会管理药学。

Brief Analysis of FDA Approved Orphan Drugs
Yinghui YU1, Yang TAN1, Guiliang CHEN2, *
Affiliations
  • 1.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200040
  • 2.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203
出版时间: 2024-01-10 doi: 10.16522/j.cnki.cjph.2024.01.018
文章导航
收藏切换

文章分析了目前美国的孤儿药认证和获批情况。从1983年1月4日到2023年6月30日,FDA共授予了4 868个通用名药物6 749个孤儿药认证,其中700个药物已获得FDA批准上市。这些获批的孤儿药来自328家企业,其中大型跨国药企在孤儿药开发中发挥着重要作用。在获批孤儿药的适应证中,仅269种被Orphanet数据库收录,覆盖率不足5%。获批孤儿药的种类较多,以化学药为主,其中寡核苷酸等多种新型孤儿药也获批上市;另外,在生物药中,细胞和基因治疗是近年来出现的新类别。总体而言,美国孤儿药政策促进了药物的研发,我国在制定相关政策时可借鉴美国的研发管理经验,要从罕见病患者角度出发,确保药物研发满足真正的临床需求。

FDA  /  孤儿药  /  研发
俞颖慧, 谭洋, 陈桂良. FDA获批孤儿药情况简析. 中国医药工业杂志, 2024 , 55 (1) : 132 -136 . DOI: 10.16522/j.cnki.cjph.2024.01.018
Yinghui YU, Yang TAN, Guiliang CHEN. Brief Analysis of FDA Approved Orphan Drugs[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (1) : 132 -136 . DOI: 10.16522/j.cnki.cjph.2024.01.018

参考文献 引证文献
排序方式:
[1]
TAMBUYZER E, VANDENDRIESSCHE B, AUSTIN C P,et al.Therapies for rare diseases: therapeutic modalities, progress and challenges ahead [J].Nat Rev Drug Discov, 2020, 19(2): 93-111.
[2]
RHEE T G.Policymaking for orphan drugs and its challenges [J].AMA J Ethics, 2020, 17(8): 776-779.
[3]
黄方如,邵文斌.中国罕见病药物可及性报告2019 [EB/OL].(2019-02-28)[2023-07-29].https://www.iqvia.com/zh-cn/locations/china/library/brochures/viewpoint-issue-42.
[4]
YANG Y, KANG Q, HU J, et al.Accessibility of drugs for rare diseases in China: policies and current situation [J].Intractable Rare Dis Res, 2019, 8(2): 80-88.
[5]
王雪,刘丽华,张绮,等.浅析美国罕见病治疗药物激励政策发展及对我国的启示[J].中国临床药理学杂志,2020,36(12):1768-1772.
[6]
Food & Drug Administration.FDA’s office of orphan products development(OOPD)-an overview and update[EB/OL].(2022-03-01)[2023-08-23].https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/fdas-office-orphan-products-development-oopd-overview-and-update.
[7]
杜涛,龚兆龙,高翼.美国孤儿药开发的政策、策略与实践[J].药学进展,2015,39(8):566-570.
[8]
Food & Drug Administration.Rare disease day 2021: FDA shows sustained support of rare disease product development during the public health emergency [EB/OL].(2021-03-01)[2023-08-23].https://www.fda.gov/news-events/fda-voices/rare-disease-day-2021-fda-shows-sustained-support-rare-disease-product-development-during-public.
[9]
Food & Drug Administration.New drug approvals for 2022 [EB/OL].(2023-09-19)[2023-07-29].https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2022.
[10]
CHRISTEL M.2023 Pharm exec top 50 companies [EB/OL].(2023-06-11)[2023-07-29].https://www.pharmexec.com/view/2023-pharm-exec-top-50-companies.
[11]
SENIOR M, HADJIVASILIOU A.Orphan drug report 2022[EB/OL].(2022-04-27)[2023-07-29].https://www.evaluate.com/thought-leadership/pharma/orphan-drug-2022-report.
[12]
田苗,田红,解学星,等.罕见病用药现状分析[J].现代药物与临床,2014,29(7):701-707.
[13]
AHIP.The rise of orphan drugs [EB/OL].(2019-09-10)[2023-07-29].https://www.ahip.org/resources/the-rise-of-orphan-drugs.
[14]
FU Z, LI S, HAN S, et al.Antibody drug conjugate: the “biological missile” for targeted cancer therapy [J].Signal Transduct Target Ther, 2022, 7(1): 93.
[15]
ROBERTS T C, LANGER R, WOOD M J A. Advances in oligonucleotide drug delivery [J]. Nat Rev Drug Discov, 2020, 19(10): 673-694.
[16]
CAPPELL K M.KOCHENDERFER J N.Long-term outcomes following CAR T cell therapy: what we know so far [J].Nat Rev Clin Oncol, 2023, 20(6): 359-371.
[17]
李玉欢,李伟.罕见病的基因治疗研究进展[J].罕少疾病杂志,2023,30(3):109-112.
[18]
BENNETT J, MAGUIRE A M.Lessons learned from the development of the first FDA-approved gene therapy frug, voretigene neparvovec-rzyl [J].Cold Spring Harb Perspect Med, 2023, 13(5): a041307.
[19]
WELLMAN-LABADIE O, ZHOU Y.The US orphan drug act: rare disease research stimulator or commercial opportunity? [J].Health policy, 2010, 95(2/3): 216-228.
[20]
Johnson & Johnson.Johnson & Johnson to acquire actelion for $30 billion with spin-out of new R&D company [EB/OL].[2023-08-22].https://www.jnj.com/media-center/press-releases/johnson-johnson-to-acquire-actelion.
[21]
THE WALL STREET JOURNAL.At Takeda, M&A integration on a global fast track [EB/OL].(2021-12-11)[2023-08-22].https://deloitte.wsj.com/articles/at-takeda-m-a-integration-on-a-global-fast-track-01639165761.
[22]
AstraZeneca.AstraZeneca to acquire Alexion, accelerating the company’s strategic and financial development [EB/OL].(2020-12-12)[2023-08-22].https://www.astrazeneca.com/media-centre/press-releases/2020/astrazeneca-to-acquire-alexion.html#!.
[23]
AMGEN.Rule 2.7 announcement: amgen inc to acquire horizon therapeutics plc [EB/OL].(2022-12-12)[2023-08-22].https://www.amgen.com/newsroom/press-releases/2022/12/rule-2-7-announcement-amgen-inc-to-acquire-horizon-therapeutics-plc.
[24]
人民网.《中国罕见病定义研究报告2021》发布[EB/OL].(2021-09-13)[2023-08-22].http://health.people.com.cn/n1/2021/0913/c14739-32225468.html.
[25]
WU X, XU W, YU M.Clinical trials of orphan drugs in China over the decade 2012-2022: opportunities and challenges [J].Pharmacol Res, 2022, 182: 106349.
2024年第55卷第1期
32
9
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.01.018
  • 接收时间:2023-09-01
  • 首发时间:2026-11-19
  • 出版时间:2024-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-09-01
基金
作者信息
    1.中国医药工业研究总院中国医药工业信息中心,上海 200040
    2.上海药品审评核查中心,上海 201203

通讯作者:

陈桂良(1964—),男,研究员,博士生导师,从事药品监管科学。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.01.018
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏